510(k) K240670 ยท DKZ Enzyme Immunoassay, Amphetamine
DRI Ecstasy Plus Assay
| Applicant | Microgenics Corporation, Fremont CA, US |
| Decision | Substantially Equivalent, Oct 30, 2024 |
| Received | Mar 11, 2024 |
| Type | Special |
| FDA record | Open on fda.gov |
Recalls that name K240670
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.